These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1569606)

  • 21. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
    Laporte AM; Koscielniak T; Ponchant M; Vergé D; Hamon M; Gozlan H
    Synapse; 1992 Apr; 10(4):271-81. PubMed ID: 1585260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
    Gordon JC; Barefoot DS; Sarbin NS; Pinkus LM
    J Pharmacol Exp Ther; 1989 Dec; 251(3):962-8. PubMed ID: 2600824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
    Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel discovery of IK1 channel agonist: zacopride selectively enhances IK1 current and suppresses triggered arrhythmias in the rat.
    Liu QH; Li XL; Xu YW; Lin YY; Cao JM; Wu BW
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):37-48. PubMed ID: 21921806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of 5-HT2C receptors in the m-CPP-induced antinociception in mice.
    Chojnacka-Wójcik E; Kłodzińska A; Dereń-Wesołek A
    Pol J Pharmacol; 1994; 46(5):423-8. PubMed ID: 7894529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative measurement of zacopride in human plasma and urine by combined gas chromatography/negative ion chemical ionization mass spectrometry.
    Girault J; Longueville D; Ntzanis L; Couffin S; Fourtillan JB
    Biol Mass Spectrom; 1994 Sep; 23(9):572-80. PubMed ID: 7948050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of emetic and antiemetic activity.
    Burkman AM
    J Pharmacol Methods; 1982 Nov; 8(3):165-71. PubMed ID: 7154672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Emetic and antiemetic properties of regulatory peptides].
    Iasnetsov VV; Drozd IuV; Shashkov VS
    Biull Eksp Biol Med; 1987 May; 103(5):586-8. PubMed ID: 2439138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
    Ashby CR; Edwards E; Wang RY
    Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution and characterisation of the [3H](S)-zacopride labelled 5-HT3 receptor in pig forebrain.
    Fletcher S; Barnes NM
    Brain Res; 1996 Aug; 729(2):281-4. PubMed ID: 8877001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pilotropic activity of silatranes].
    Voronkov MG; Bakhareva EV; Kuznetsov IG
    Dokl Akad Nauk SSSR; 1982; 262(3):736-9. PubMed ID: 7060453
    [No Abstract]   [Full Text] [Related]  

  • 33. Bicyclo((aryl)methyl)benzamides as inhibitors of GlyT1.
    Varnes JG; Xiong H; Forst JM; Holmquist CR; Ernst GE; Frietze W; Dembofsky B; Andisik DW; Palmer WE; Hinkley L; Steelman GB; Wilkins DE; Tian G; Jonak G; Potts WM; Wang X; Brugel TA; Alhambra C; Wood MW; Veale CA; Albert JS
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1043-1049. PubMed ID: 29486970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
    Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of IK1 channel by zacopride attenuates left ventricular remodeling in rats with myocardial infarction.
    Liu CF; Liu QH; Liu EL; Zhai XW; Zhang L; Luo TE; Zhang WF; Feng QL; Cui XL; Zhao ZQ; Cao JM; Wu BW
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):345-56. PubMed ID: 25286360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of zacopride, a moderate I
    Elnakish MT; Canan BD; Kilic A; Mohler PJ; Janssen PM
    Pharmacol Res; 2017 Jan; 115():309-318. PubMed ID: 27914945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [TECHNIC FOR THE STUDY OF THE CENTRAL ACTION OF EMETIC AND ANTIEMETIC POISONS].
    MALMEJAC J; LAVILLE C; MARGARIT J
    C R Seances Soc Biol Fil; 1964; 158():964-5. PubMed ID: 14234614
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of Y-25130, a selective 5-hydroxytryptamine3 receptor antagonist, on gastric emptying in mice.
    Haga K; Asano K; Inaba K; Morimoto Y; Setoguchi M
    Arch Int Pharmacodyn Ther; 1994; 328(3):344-55. PubMed ID: 7625886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response relationship of ramipril in patients with mild-to-moderate hypertension.
    Schnaper HW
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S128-30. PubMed ID: 1725021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paradoxical emetic response to antiemetic treatment in cancer patients.
    Kutz I; Borysenko JZ; Come SE; Benson H
    N Engl J Med; 1980 Dec; 303(25):1480. PubMed ID: 7432413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.